Hematogenix
Noorzaihan Mat Radi is an experienced project manager currently working at Hematogenix since August 2021. Prior to this role, Noorzaihan served as a Regulatory Start Up Specialist 2 and Feasibility Site ID Specialist at IQVIA from March 2021 to June 2021. Additionally, Noorzaihan held multiple positions at Clinical Research Malaysia from February 2016 to March 2021, including Associate Feasibility Manager, Senior Feasibility Specialist, and Feasibility Specialist. Noorzaihan holds a Doctor of Medicine (MD) degree from Universiti Kebangsaan Malaysia, earned between 2009 and 2014.
This person is not in any offices
Hematogenix
1 followers
Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services such as Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology and Image Analysis. Our test menu reflects our commitment to utilizing the most advanced techniques to enhance patient care. We provide customized services ranging from the initial stages of research to development, and extending all the way to the implementation of targeted therapies in the clinical setting. * CAP – Accredited * CLIA – Certified * GCP – Compliant